Published in J Infect Dis on October 17, 2000
New adhesin of enteroaggregative Escherichia coli related to the Afa/Dr/AAF family. Infect Immun (2008) 1.91
Typical enteroaggregative Escherichia coli is the most prevalent pathotype among E. coli strains causing diarrhea in Mongolian children. J Clin Microbiol (2004) 1.59
Short report: high prevalence of serine protease autotransporter cytotoxins among strains of enteroaggregative Escherichia coli. Am J Trop Med Hyg (2009) 1.43
Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl Environ Microbiol (2007) 1.43
Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol (2002) 1.23
Etiology of acute diarrhea in adults in southwestern Nigeria. J Clin Microbiol (2003) 1.21
Molecular epidemiology of the iron utilization genes of enteroaggregative Escherichia coli. J Clin Microbiol (2004) 1.12
Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection. J Clin Microbiol (2013) 1.07
Characterization of the AggR regulon in enteroaggregative Escherichia coli. Infect Immun (2012) 0.98
Comparative analysis of virulence genes, genetic diversity, and phylogeny of commensal and enterotoxigenic Escherichia coli isolates from weaned pigs. Appl Environ Microbiol (2006) 0.97
Aetiology of diarrhoea and virulence properties of diarrhoeagenic Escherichia coli among patients and healthy subjects in southeast Nigeria. J Health Popul Nutr (2010) 0.97
Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea. Gut Microbes (2014) 0.96
Association of putative pathogenicity genes with adherence characteristics and fimbrial genotypes in typical enteroaggregative Escherichia coli from patients with and without diarrhoea in the United Kingdom. Eur J Clin Microbiol Infect Dis (2007) 0.93
Enteroaggregative Escherichia coli strain in a novel weaned mouse model: exacerbation by malnutrition, biofilm as a virulence factor and treatment by nitazoxanide. J Med Microbiol (2013) 0.92
Two novel EHEC/EAEC hybrid strains isolated from human infections. PLoS One (2014) 0.90
Heterogeneity among strains of diffusely adherent Escherichia coli isolated in Brazil. J Clin Microbiol (2005) 0.89
Presence of multi-drug resistant pathogenic Escherichia coli in the San Pedro River located in the State of Aguascalientes, Mexico. Front Microbiol (2013) 0.87
Heteropathogenic virulence and phylogeny reveal phased pathogenic metamorphosis in Escherichia coli O2:H6. EMBO Mol Med (2014) 0.83
Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru). Int J Med Microbiol (2015) 0.81
Combination vaccines against diarrheal diseases. Hum Vaccin Immunother (2015) 0.80
Occurrence of genes encoding enterotoxins in uropathogenic Escherichia coli isolates. Braz J Microbiol (2015) 0.80
Molecular characterization and antibiotic resistance of enterotoxigenic and entero-aggregative Escherichia coli isolated from raw milk and unpasteurized cheeses. Vet Res Forum (2014) 0.80
Enteroaggregative Escherichia coli: An Emerging Pathogen. Curr Infect Dis Rep (2004) 0.76
Characterisation of Commensal Escherichia coli Isolated from Apparently Healthy Cattle and Their Attendants in Tanzania. PLoS One (2016) 0.75
Adherence and virulence genes of Escherichia coli from children diarrhoea in the Brazilian Amazon. Braz J Microbiol (2015) 0.75
The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis (1985) 9.18
Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe. J Infect Dis (1985) 7.78
Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Escherichia coli. Infect Immun (1985) 5.42
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis (1988) 5.30
The great escape: structure and function of the autotransporter proteins. Trends Microbiol (1998) 4.72
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J Clin Invest (1993) 4.53
Virulence functions of autotransporter proteins. Infect Immun (2001) 4.07
A plasmid-encoded type IV fimbrial gene of enteropathogenic Escherichia coli associated with localized adherence. Mol Microbiol (1992) 3.93
Molecular switches--the ON and OFF of bacterial phase variation. Mol Microbiol (1999) 3.69
Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli. J Infect Dis (1988) 3.19
Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect Immun (1999) 2.78
Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis (1998) 2.59
Identification of sat, an autotransporter toxin produced by uropathogenic Escherichia coli. Mol Microbiol (2000) 2.53
Localization of a determinant for HEp-2 adherence by enteropathogenic Escherichia coli. Infect Immun (1986) 2.52
Phylogenetic analysis of enteroaggregative and diffusely adherent Escherichia coli. Infect Immun (1999) 2.51
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli. Infect Immun (1998) 2.49
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun (1997) 2.44
Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet (1989) 2.22
Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill (2011) 2.18
Vibrio cholerae O1 can assume a chlorine-resistant rugose survival form that is virulent for humans. J Infect Dis (1996) 2.17
Heterogeneous virulence of enteroaggregative Escherichia coli strains isolated from children in Southwest Nigeria. J Infect Dis (2000) 2.12
Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol (1999) 2.11
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis (1995) 2.10
espC pathogenicity island of enteropathogenic Escherichia coli encodes an enterotoxin. Infect Immun (2001) 2.03
Persistent diarrhea signals a critical period of increased diarrhea burdens and nutritional shortfalls: a prospective cohort study among children in northeastern Brazil. J Infect Dis (2000) 2.01
Serum lactate dehydrogenase as early marker of posterior reversible encephalopathy syndrome: keep your eyes open. Anaesth Intensive Care (2012) 2.01
Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J Clin Invest (2000) 1.96
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis (1992) 1.94
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. J Infect Dis (1993) 1.93
Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection. Infect Immun (1998) 1.90
Four-year water degradation of total-etch adhesives bonded to dentin. J Dent Res (2003) 1.83
Etiology and epidemiology of persistent diarrhea in northeastern Brazil: a hospital-based, prospective, case-control study. J Pediatr Gastroenterol Nutr (1995) 1.82
Roles for Fis and YafK in biofilm formation by enteroaggregative Escherichia coli. Mol Microbiol (2001) 1.80
Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J Infect Dis (1995) 1.75
Plasmodium falciparum: inhibition of sporogonic development in Anopheles stephensi by gram-negative bacteria. Exp Parasitol (1993) 1.75
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine (1995) 1.74
Diarrhea in children under 5 years of age from Ifakara, Tanzania: a case-control study. J Clin Microbiol (2000) 1.72
Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J Clin Microbiol (1992) 1.71
Cytoskeletal effects induced by pet, the serine protease enterotoxin of enteroaggregative Escherichia coli. Infect Immun (1999) 1.65
Longitudinal study of Cryptosporidium infection in children in northeastern Brazil. J Infect Dis (1999) 1.64
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun (2000) 1.63
Identification and characterization of a gene cluster mediating enteroaggregative Escherichia coli aggregative adherence fimbria I biogenesis. J Bacteriol (1994) 1.62
Enteroaggregative Escherichia coli. Lancet Infect Dis (2001) 1.59
The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation. Infect Immun (2000) 1.55
Autotransporter proteins, evolution and redefining protein secretion. Trends Microbiol (2000) 1.54
Schistosomiasis of the male genital tract: transrectal sonographic findings. J Urol (1997) 1.52
The response to IV rt-PA in very old stroke patients. Eur J Neurol (2008) 1.52
In vitro effects of a high-molecular-weight heat-labile enterotoxin from enteroaggregative Escherichia coli. Infect Immun (1998) 1.51
Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon (2010) 1.50
Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111. Am J Trop Med Hyg (1997) 1.48
Role of EspB in experimental human enteropathogenic Escherichia coli infection. Infect Immun (2000) 1.47
[Neurocysticercosis: an imported disease?]. Med Clin (Barc) (2001) 1.45
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect Immun (2000) 1.44
The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke (2005) 1.44
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J Infect Dis (1994) 1.43
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect Immun (1997) 1.43
[Primary health care and cooperation with the Third World]. Med Clin (Barc) (1992) 1.39
[Severe neuropsychiatric reaction following mefloquine use]. Med Clin (Barc) (1993) 1.39
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2. Vaccine (1995) 1.38
Methods for studying adhesion of diarrheagenic Escherichia coli. Methods Enzymol (1995) 1.35
Organization of biogenesis genes for aggregative adherence fimbria II defines a virulence gene cluster in enteroaggregative Escherichia coli. J Bacteriol (1999) 1.34
Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi. Infect Immun (1988) 1.33
Outbreak of 2009 pandemic influenza A(H1N1), Los Lagos, Chile, April-June 2009. Euro Surveill (2010) 1.32
Use of a short fragment of the C-terminal E gene for detection and characterization of two new lineages of dengue virus 1 in India. J Clin Microbiol (2006) 1.32
Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect Immun (1996) 1.32
Interpreting genotype × environment interaction in tropical maize using linked molecular markers and environmental covariables. Theor Appl Genet (1999) 1.30
Molecular epidemiology of non-O1 Vibrio cholerae and Vibrio mimicus in the U.S. Gulf Coast region. J Clin Microbiol (1986) 1.29
Hemolysin-positive enteroaggregative and cell-detaching Escherichia coli strains cause oncosis of human monocyte-derived macrophages and apoptosis of murine J774 cells. Infect Immun (1998) 1.29
Involvement of the enteroaggregative Escherichia coli plasmid-encoded toxin in causing human intestinal damage. Infect Immun (1999) 1.27
Improved Methods for Cultivation of the Extremely Thermophilic Bacterium Thermotoga neapolitana. Appl Environ Microbiol (1992) 1.27
Plasmid-encoded toxin of enteroaggregative Escherichia coli is internalized by epithelial cells. Infect Immun (2001) 1.25
Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. Vaccine (1994) 1.24
Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge. Infect Immun (1998) 1.23
Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun (1998) 1.23
Pet toxin from enteroaggregative Escherichia coli produces cellular damage associated with fodrin disruption. Infect Immun (2000) 1.22
Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry (2006) 1.21
A longitudinal study of Giardia lamblia infection in north-east Brazilian children. Trop Med Int Health (2001) 1.16
C-terminal amino acid residues of the trimeric autotransporter adhesin YadA of Yersinia enterocolitica are decisive for its recognition and assembly by BamA. Mol Microbiol (2010) 1.16
Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania. Antimicrob Agents Chemother (1999) 1.14
Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus. Vaccine (2000) 1.12
Enteroaggregative Escherichia coli strains as a cause of traveler's diarrhea: a case-control study. J Infect Dis (1998) 1.11
Characterization of HEp-2 cell projection formation induced by diffusely adherent Escherichia coli. Microb Pathog (1996) 1.10
The orientation of a tandem POTRA domain pair, of the beta-barrel assembly protein BamA, determined by PELDOR spectroscopy. Structure (2009) 1.06
[Report of 72 cases of imported malaria]. Rev Clin Esp (1989) 1.06
Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility. J Travel Med (1998) 1.03
Homology-driven assembly of a sequence-ready mouse BAC contig map spanning regions related to the 46-Mb gene-rich euchromatic segments of human chromosome 19. Genomics (2001) 1.02
A case-control study of diarrhoea in children caused by Escherichia coli producing heat-stable enterotoxin (EAST-1). J Med Microbiol (1998) 1.00
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru. Infect Immun (1997) 0.99
Recent advances in genetic analyses of hyperthermophilic archaea and bacteria. Arch Microbiol (1997) 0.99
Comparative, clinico-epidemiologic study of Schistosoma mansoni infections in travellers and immigrants in Spain. Eur J Clin Microbiol Infect Dis (2002) 0.98
Characterization of the AfaD-like family of invasins encoded by pathogenic Escherichia coli associated with intestinal and extra-intestinal infections. FEBS Lett (2000) 0.97
Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O. Trans R Soc Trop Med Hyg (1995) 0.97
Short report: characterization of enteroaggregative Escherichia coli isolates from Iranian children. Am J Trop Med Hyg (2001) 0.97
Electrophysiological characterization of murine myocardial ischemia and infarction. Basic Res Cardiol (2001) 0.97